-

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Live Nation Entertainment, Inc. Investors to Inquire About Securities Class Action Investigation – LYV

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Live Nation Entertainment, Inc. (NYSE: LYV) resulting from allegations that Live Nation may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Live Nation securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=2702 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

WHAT IS THIS ABOUT: On November 5, 2021, the Astroworld tragedy occurred, resulting in at least 9 deaths, hundreds of injuries, and the hospitalization of 25 people. Live Nation promoted the event.

According to an Associated Press article entitled “Crowd surge kills at least 8 at Houston music festival,” the crowd at Astroworld “suddenly surged toward the stage during a performance by rapper Travis Scott, squeezing fans so tightly together that they could not breathe or move their arms and killing eight people in the chaos.” The article also noted that “[s]ome audience members said barricades erected near the stage and to separate different sections of ticket holders prevented fans from escaping.”

Since the tragedy, dozens of lawsuits have been filed against Live Nation, many of which allege that the concert organizers created conditions that caused the stampedes and failed to provide proper safety planning, security, and medical personnel. According to a Billboard article, “[e]xperts have told Billboard that the litigation over the deadly event – which left eight dead and scores more injured – could ultimately see hundreds of individual claims and that potential damages or settlements could reach hundreds of millions of dollars.”

On this news, Live Nation’s share price fell 5% on November 8, 2021, the next trading day after the tragedy.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
cases@rosenlegal.com
pkim@rosenlegal.com
www.rosenlegal.com

Rosen Law Firm

NYSE:LYV


Contacts

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
cases@rosenlegal.com
pkim@rosenlegal.com
www.rosenlegal.com

More News From Rosen Law Firm

MNDY Deadline: Rosen Law Firm Urges monday.com Ltd. (NASDAQ: MNDY) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of common stock of monday.com Ltd. (NASDAQ: MNDY) between September 17, 2025 and February 6, 2026. monday.com describes itself as an “international company that develops software applications in the United States, Europe, the Middle East, Africa and the United Kingdom.” For more information, submit a form, email attorney Phillip Kim, or give us a c...

CWH Deadline: Rosen Law Firm Urges Camping World Holdings, Inc. (NYSE: CWH) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of Camping World Holdings, Inc. (NYSE: CWH) securities between April 29, 2025 and February 24, 2026. Camping World retails recreational vehicles (“RVs”) and related products and services in the United States. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Invest...

Rosen Law Firm Urges Immutep Ltd. (NASDAQ: IMMP) Stockholders to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of American Depositary Receipts (“ADRs”) of Immutep Ltd. (NASDAQ: IMMP) between March 24, 2025 and March 12, 2026. Immutep describes itself as an “Australian-based biotechnology company focused on developing Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune diseases.” For more information, submit a form, email attorney Philli...
Back to Newsroom